Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

MRTXMRTX
22 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in MIRATI THERAPEUTICS INC

As of its Q4 2023 13F, Charles Schwab Investment Management held 365,428 shares of MRTX (Mirati Therapeutics), worth $21.5M. Charles Schwab Investment Management's 13F filings listed MRTX from Q4 2018 to Q4 2023, 21 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$6.5M

Total Shares Change

-153,326

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q1
Latest
Exited
0
-100.0%
$00.0%—
0
2023-Q4
Increased
365,428
+6.4%
$21.5M0.0%—
30
2023-Q3
Decreased
343,442
-21.2%
$15M0.0%—
0
2023-Q2
Increased
436,048
+1.3%
$15.8M0.0%—
28
2023-Q1
Decreased
430,494
-0.3%
$16M0.0%—
0
2022-Q4
Increased
431,963
+6.9%
$19.6M0.0%—
30
2022-Q3
Increased
404,174
+2.9%
$28.2M0.0%—
30
2022-Q2
Decreased
392,900
-0.0%
$26.4M0.0%—
0
2022-Q1
Increased
392,958
+2.8%
$32.3M0.0%—
30
2021-Q4
Increased
382,429
+10.2%
$56.1M0.0%—
32
2021-Q3
Increased
347,025
+1.4%
$61.4M0.0%—
30
2021-Q2
Decreased
342,268
-17.9%
$55.3M0.0%—
0
2021-Q1
Increased
416,798
+2.7%
$71.4M0.0%—
30
2020-Q4
Increased
405,663
+16.5%
$89.1M0.0%—
35
2020-Q3
Increased
348,328
+33.3%
$57.8M0.0%—
38
2020-Q2
Increased
261,255
+14.5%
$29.8M0.0%—
33
2020-Q1
Increased
228,136
+17.0%
$17.5M0.0%—
33
2019-Q4
Increased
195,051
+2.8%
$25.1M0.0%—
29
2019-Q3
Increased
189,771
+5.3%
$14.8M0.0%—
30
2019-Q2
Increased
180,306
+6.5%
$18.6M0.0%—
30
2019-Q1
Increased
169,314
+10.4%
$12.4M0.0%—
31
2018-Q4
First report
153,326
-
$6.5M0.0%—
0

Other major holders of MRTX: Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used